Outpatient PE Management — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Yes — low-risk PE (sPESI 0 with normal troponin and RV function) can be managed with early discharge and outpatient anticoagulation using a DOAC, per the Hestia criteria or sPESI pathway; this applies to approximately 30-50% of PE patients
The ESC 2019 PE Guidelines recommend risk stratification using sPESI or Hestia criteria to identify low-risk PE patients suitable for early discharge: (1) sPESI = 0 (no adverse features) AND normal troponin AND normal RV on echo/CT → low-risk; (2) Hestia criteria: checklist of 11 exclusion criteria (haemodynamic instability, need for thrombolysis, active bleeding, need for oxygen, IV pain management, etc.) — if all negative, early discharge is safe. Home treatment: DOAC monotherapy (rivaroxaban 15 mg bd × 3 weeks then 20 mg daily, or apixaban 10 mg bd × 7 days then 5 mg bd). Studies (HOME-PE, OPTALYSE PE) confirm safety of outpatient management for low-risk PE with 30-day mortality <2% and VTE recurrence <2%. This approach reduces healthcare costs and improves patient satisfaction.
Reference: ESC (2019): PE Guidelines; HOME-PE Trial